These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Anticoagulation management associated with extracorporeal circulation. Sniecinski RM; Levy JH Best Pract Res Clin Anaesthesiol; 2015 Jun; 29(2):189-202. PubMed ID: 26060030 [TBL] [Abstract][Full Text] [Related]
44. Ex vivo testing of heparin-coated extracorporeal circuits: bovine experiments. Weerwind PW; van der Veen FH; Lindhout T; de Jong DS; Cahalan PT Int J Artif Organs; 1998 May; 21(5):291-8. PubMed ID: 9684912 [TBL] [Abstract][Full Text] [Related]
45. [Cardiopulmonary bypass over 24 hours without systemic anticoagulation: new horizons?]. von Segesser LK; Turina M Helv Chir Acta; 1990 Oct; 57(2):389-93. PubMed ID: 2074206 [TBL] [Abstract][Full Text] [Related]
46. Heparin-coated extracorporeal circulation with full and low dose heparinization: comparison of thrombin related coagulatory effects. Mirow N; Brinkmann T; Minami K; Tenderich G; Kleesiek K; Körfer R Artif Organs; 2001 Jun; 25(6):480-5. PubMed ID: 11453879 [TBL] [Abstract][Full Text] [Related]
48. Diffusion-weighted magnetic resonance imaging for the detection of ischemic brain lesions in coronary artery bypass graft surgery: relation to extracorporeal circulation and heparinization. Mirow N; Zittermann A; Körperich H; Börgermann J; Koertke H; Knobl H; Gieseke J; Ostertun B; Coskun T; Kleesiek K; Burchert W; Gummert JF J Cardiovasc Surg (Torino); 2011 Feb; 52(1):117-26. PubMed ID: 21224820 [TBL] [Abstract][Full Text] [Related]
49. Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit. Moen O; Fosse E; Bråten J; Andersson C; Høgåsen K; Mollnes TE; Venge P; Kierulf P Perfusion; 1996 Mar; 11(2):113-23. PubMed ID: 8740352 [TBL] [Abstract][Full Text] [Related]
50. [The principles of minimal extracorporeal circulation and its uses]. Göbölös L; Hejjel L; Lindenmayer-G R; Wiebe K; Philipp A; Foltan M; Ziegler S; Imre J; Sipos E; Gyorimolnár I; Papp L Orv Hetil; 2007 Nov; 148(46):2167-71. PubMed ID: 17988973 [TBL] [Abstract][Full Text] [Related]
51. New methods for surface modification and covalent attachment of heparin. al-Lamee K; Taktak Y Med Device Technol; 1998; 9(1):24-7. PubMed ID: 10176141 [TBL] [Abstract][Full Text] [Related]
52. [Heparin concentration and hemostatic alterations with low systemic heparinization during CPB using heparin-coated circuits]. Yoshie M; Hirose Y; Gamo M; Matsuo K Masui; 2001 Feb; 50(2):179-83. PubMed ID: 11244775 [TBL] [Abstract][Full Text] [Related]
54. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits. Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955 [TBL] [Abstract][Full Text] [Related]
55. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Nilsson L; Storm KE; Thelin S; Bagge L; Hultman J; Thorelius J; Nilsson U Artif Organs; 1990 Feb; 14(1):46-8. PubMed ID: 2302076 [TBL] [Abstract][Full Text] [Related]
56. Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin. Mollnes TE; Videm V; Götze O; Harboe M; Oppermann M Ann Thorac Surg; 1991 Jul; 52(1):92-7. PubMed ID: 2069469 [TBL] [Abstract][Full Text] [Related]
57. Improved blood cellular biocompatibility with heparin coated circuits during cardiopulmonary bypass. Belboul A; Akbar O; Löfgren C; Jungbeck M; Storm C; Roberts A J Cardiovasc Surg (Torino); 2000 Jun; 41(3):357-62. PubMed ID: 10952323 [TBL] [Abstract][Full Text] [Related]